NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002947

Registered date:28/12/2009

Evaluation of efficacy and safety of riboflavin/UVA treatment for keratoconus/keratectasia

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedKeratoconus, keratectasia
Date of first enrollment2009/02/01
Target sample size30
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Collagen fibers of the corneal stroma will be crosslinked by the combination of instillation of riboflavin solution and ultraviolet-A irradiation for 30 minutes after corneal epithelial debridement.

Outcome(s)

Primary OutcomeVisual acuity, refraction, corneal curvature, corneal topography, corneal endothelial cell counts, and incidence of complications
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum14years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. The corneal thickness less than 400 micrometer 2. Those who implanted medical instruments, such as pacemaker. 3. Ocular diseases, such as infection, corneal scar, herpetic keratitis, and/or nystagmus 4. Systemic diseases affecting corneal would healing 5. Eyes with narrow angle. Pregnant or breast-feeding women. 6. Occupation, by which refractive surgery is not arrowed

Related Information

Contact

public contact
Name Naoko Kato
Address Shinanomachi 35, Shinjuku-ku, Tokyo Japan
Telephone 03-3353-1211
E-mail nkato@ndmc.ac.jp
Affiliation Keio University School of Medicine Department of Ophthalmology, Refractive Surgery Clinic
scientific contact
Name Kazuo Tsubota
Address Shinanomachi 35, Shinjuku-ku, Tokyo Japan
Telephone 03-3353-1211
E-mail keio.eye.research.sec@gmail.com
Affiliation Keio University School of Medicine Department of Ophthalmology